NVAX Update (Responding to Some Requests)I wrote this in response to a comment on a previous update, but I'm publishing this here because some others have requested an update as well.
Remember: I'm just some dude on the internet and I'm not a financial advisor. So please keep that in mind.
For me, personally, NVAX is a patience game. I
Key facts today
Shares of Novavax (NVAX) fell by 5.2% after the announcement of Vinay Prasad's appointment as the director of the FDA's Center for Biologics Evaluation and Research (CBER).
NVAX Potential Breakout!Potential Breakout in the next week for NVAX. Would not be surprised to see a move to around $10.60 in the next few days. If it can break the bigger wedge, a potential big upside to around $14-$15 range.
Besides this short term idea, the stock has even greater upside from a TA point of view if you
$NVAX - GAP FILL & BREAK OF TRANEDLINE NASDAQ:NVAX gaining momentum again along with other pharma's. Its interestingly filling the gap anf has i high possibility of retesting the high of the channel. I have a starter position and will be adding if it decides to test the trend line. A daily close below the trendline is my stop. Playing e
Shot At Vaccinating Gains!Novavax (NVAX) is demonstrating strong bullish momentum, with a gap forming around the $8.75 level. A breakout above the $14.60 monthly resistance would confirm continued strength, positioning the stock to target $23.71. This trade offers an excellent risk-to-reward ratio, with downside risk managed
Novavax Set to Soar: A Bullish Breakout in Sight?Unveiling the Potential of NVAX
Novavax (NVAX), a notable biopharmaceutical stock, has witnessed a dramatic journey, plunging from its February 2021 high of approximately $330 to a critical low of $3.53 in February 2024. While this decline may appear daunting, our technical analysis suggests that i
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.